| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |